Press Releases

Date Headline
Zymeworks to Present at J.P. Morgan Healthcare Conference and Host Two Webcasts in January to Provide Updates on its Lead Clinical Programs Zanidatamab and ZW49
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming 39 th  Annual J.P. Morgan Healthcare Conference.  Continue Reading
Displaying 21 - 21 of 21
Copyright 2021 , Zymeworks Inc.